Advion Expands Its Bioanalytical Capabilities with Investment in New API 5000 and API 4000 Mass Spectrometers from Applied Biosystems/MDS Analytical Technologies

Dedicated to Science, Dedicated to You

July 1, 2008 – Ithaca , NY – Advion BioServices, Inc., a specialty contract research organization, today announced that it has expanded its bioanalytical service capabilities by adding five new triple quadrupole mass spectrometers to its laboratory in Ithaca, New York. Included in this investment are the industry-leading API 5000™ LC/MS/MS System and API 4000™ LC/MS/MS System from Applied Biosystems/MDS Analytical Technologies, a leader in mass spectrometry.

With this purchase, Advion brings its total of new mass spectrometers acquired in the past year to seven. These additional instruments provide Advion with increased LC/MS capacity to meet growing client demands and the ability to provide its clients with an expanding array of bioanalytical services.

According to Jack Henion, PhD, Chief Scientific Officer, Advion, “Utilizing state-of-the-art instrumentation is an important focus for Advion. We are committed to remaining leaders of scientific excellence in bioanalysis and the purchase of these mass spectrometers exemplifies this focus.”

The API 5000 and API 4000 systems provide the company with the sensitivity and selectivity in analysis necessary to obtain precise and reliable testing results. The API 5000 System is ideal for the detection of low-level molecules. It couples liquid chromatography with Applied Biosystems/MDS Analytical Technologies’ QJet™ ion source technology and triple quadrupole tandem mass spectrometry (LC/MS/MS), a widely used laboratory technique for measuring pharmaceutical compounds and metabolites.

Tom Kurz, President of Commercial Operations, comments, “The increased capacity and flexibility afforded by this investment will allow us to better serve our clients’ need for timely bioanalytical services of the highest quality.”

About Advion BioServices, Inc.
Advion is a scientific leader in bioanalytical and immunoassay services. Advion offers a range of services including LC/MS/MS services, immunoassay services, dose formulation analysis, sample management and storage services. The company is the laboratory of choice for pharmaceutical and biotechnology companies demanding scientific excellence.

More information about the company can be found on its website www.advion.com.

API 4000, API 5000 and QJet are trademarks of Applied Biosystems/MDS Analytical Technologies, a joint venture between Applera Corporation and MDS Inc.

For Advion:
Heather Scollins
Senior Marketing Communication Specialist
Advion BioSciences, Inc.
P: 1.607.266.0665 ext. 333
hscollins@advion.com